Table 1

Participant demographics, medications, and disease indices
Age Sex Disease Prior treatment includes Recent treatment HBI/MTLWSI before HBI/MTLWSI after
39 F CD ASA, IM, B ASA?+?IBD-AID HBI 12 3
47 F CD S, IM, B S(taper)?+?IBD-AID HBI 9 2
39 F CD S,IM IM?+?IBD-AID HBI 12 2
24 F CD S,ASA, IM, B S(taper) IM?+?IBD-AID HBI 15 0
39 M CD IM, B IBD?+?AID HBI 20 0
40 M CD S,ASA, IM IM?+?IBD-AID HBI 15 2
41 M CD ASA, IM IM?+?IBD-AID HBI 4 2
37 F CD S,ASA, B, elemental diet B?+?IBD-AID HBI 1 1; histologic remission
69 M UC ASA, IM, B ASA, IM?+?IBD-AID MTLWSI n/d 2; improved
19 F UC S, ASA, IM, B ASA, IBD-AID MTLWSI 6 0
70 F UC ASA, IM, B B?+?IBD-AID MTLWSI 8 0

Legend:

ASA?=?5-Aminosalycylic acid agent.

IM?=?Immunomodulator.

B?=?Biologic.

S?=?Steroid.

IBD-AID?=?Inflammatory Bowel Disease-Anti-Inflammatory Diet.

HBI?=?Harvey Bradshaw Index.

MTLWSISI?=?Modified TrueLove and Witts Severity Index.

Olendzki et al.

Olendzki et al. Nutrition Journal 2014 13:5   doi:10.1186/1475-2891-13-5

Open Data